Literature DB >> 8764746

Giant cell ependymoma of the filum terminale. A report of two cases.

N Zec1, U De Girolami, D E Schofield, R M Scott, D C Anthony.   

Abstract

We describe two histologically unusual cases of ependymoma of the filum terminale. Both tumors occurred in 14-year-old boys. An intradural encapsulated mass attached to the filum terminale was demonstrated radiologically in both cases and totally resected at surgery. In case 1 the neoplasm was uniformly composed of pleomorphic giant cells and was without perivascular pseudorosettes or myxopapillary changes. Case 2 was a myxopapillary ependymoma with multiple foci of pleomorphic giant cells. Neither tumor had prominent mitotic activity, necrosis, or endothelial proliferation. Both tumors were immunopositive for cytokeratin and glial fibrillary acidic protein. Ultrastructural features included basal laminae, interdigitating cell processes, microvilli, cilia, intercellular junctions, and cytoplasmic intermediate filaments. Cytogenetic analysis in case 1 showed a hypodiploid karyotype with monosomy of chromosomes 1, 10, 14, 16, 20, and 22. We interpret both tumors as most consistent with a variant of ependymoma. Because of the unique gigantocellular light microscopic appearance of the entire tumor in case 1, we propose classifying this tumor as a new morphologic subtype: giant cell ependymoma of the filum terminale. The combination of gigantocellular and myxopapillary features in case 2 supports a histogenetic relationship between giant cell ependymoma and myxopapillary ependymoma.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8764746     DOI: 10.1097/00000478-199609000-00007

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  9 in total

Review 1.  Giant cell ependymoma-report of three cases and review of the literature.

Authors:  Jian Yi Li; Jose I Lopez; Suzanne Z Powell; Stephen W Coons; Gregory N Fuller
Journal:  Int J Clin Exp Pathol       Date:  2012-05-05

2.  Cellular pleomorphism in papillary tumors of the pineal region.

Authors:  Juliana Magalhães; Steven Rostad; Greg Foltz; Peter Pytel; Fausto J Rodriguez
Journal:  Brain Tumor Pathol       Date:  2012-05-24       Impact factor: 3.298

3.  Rare histological variants in ependymomas: histopathological analysis of 13 cases.

Authors:  Marco Gessi; Klaus Kuchelmeister; Libero Lauriola; Torsten Pietsch
Journal:  Virchows Arch       Date:  2011-07-27       Impact factor: 4.064

Review 4.  Giant cell ependymoma of the cervical spinal cord: case report and review of the literature.

Authors:  Giuseppe M V Barbagallo; Rosario Caltabiano; Giuseppe Parisi; Vincenzo Albanese; Salvatore Lanzafame
Journal:  Eur Spine J       Date:  2008-09-27       Impact factor: 3.134

Review 5.  Ependymoma.

Authors:  Charles Teo; Peter Nakaji; Patricia Symons; Vivienne Tobias; Richard Cohn; Robert Smee
Journal:  Childs Nerv Syst       Date:  2003-05-22       Impact factor: 1.475

6.  Cytologic features of giant cell ependymoma: a case report and review of the literature.

Authors:  Myoung Ju Koh; Sun Och Yoon; Hyae Min Jeon; Hyeon Joo Jeong; Soon Won Hong; Se Hoon Kim
Journal:  Korean J Pathol       Date:  2012-10-25

7.  Immunohistochemical features of giant cell ependymoma of the filum terminale with unusual clinical and radiological presentation.

Authors:  Fernando Candanedo-Gonzalez; Cindy Sharon Ortiz-Arce; Samuel Rosales-Perez; Ana Lilia Remirez-Castellanos; Candelaria Cordova-Uscanga; Armando Gamboa-Dominguez
Journal:  Diagn Pathol       Date:  2017-01-14       Impact factor: 2.644

8.  Intraoperative squash cytology and histology of giant cell ependymoma: A diagnostic dilemma.

Authors:  Ebru Cakir; Ulku Kucuk; Ayca Ersen; Emel E Pala; Mehmet Senoglu; Ali O Binatli; Zubeyde Yildirim
Journal:  J Cytol       Date:  2017 Jan-Mar       Impact factor: 1.000

9.  Outcome predictors in the management of intramedullary classic ependymoma: An integrative survival analysis.

Authors:  Yinqing Wang; Ranze Cai; Rui Wang; Chunhua Wang; Chunmei Chen
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.